Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited)

v3.22.0.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Dec. 31, 2021
Jun. 30, 2021
Current assets:    
Cash and cash equivalents $ 211,845 $ 199,091
Short-term available-for-sale investments 67,135 32,463
Accounts receivable, less allowance for doubtful accounts of $1,334 and $1,229, respectively 152,896 145,385
Inventories 121,858 116,748
Other current assets 36,496 16,919
Total current assets 590,230 510,606
Property and equipment, net 211,814 207,907
Right of use asset 64,293 73,834
Goodwill 832,056 843,067
Intangible assets, net 569,347 615,968
Other assets 37,106 11,575
Total assets 2,304,846 2,262,957
Current liabilities:    
Trade accounts payable 26,756 29,384
Salaries, wages and related accruals 43,921 51,294
Accrued expenses 18,991 15,282
Contract liabilities 19,081 18,995
Income taxes payable 14,284 5,336
Operating lease liabilities - current 11,809 11,602
Contingent consideration payable 2,000 4,000
Current portion of long-term debt obligations 12,500 12,500
Other current liabilities 5,467 3,891
Total current liabilities 154,809 152,284
Deferred income taxes 101,423 93,125
Long-term debt obligations 269,618 328,827
Long-term contingent consideration payable 7,000 25,400
Operating lease liabilities 57,718 67,625
Other long-term liabilities 11,747 24,462
Bio-Techne's Shareholders' equity:    
Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding 0 0
Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 39,319,766 and 38,955,484, respectively 393 390
Additional paid-in capital 616,429 534,411
Retained earnings 1,145,641 1,085,461
Accumulated other comprehensive loss (59,474) (57,291)
Total Bio-Techne’s shareholders' equity 1,702,989 1,562,971
Noncontrolling interest (458) 8,263
Total shareholders’ equity 1,702,531 1,571,234
Total liabilities and shareholders’ equity $ 2,304,846 $ 2,262,957